Allergy/Imm

Your Article Summary

See Latest Articles

Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis
Journal of Allergy and Clinical Immunology, 09/26/06

Joanne N.G. Oude Elberink MD, et al. - Venom immunotherapy (VIT) is a treatment with established efficacy for the prevention of repeated anaphylactic reactions in patients with Hymenoptera allergy, which also allows patients to discontinue carrying an EpiPen...Conclusion: In contrast to VIT, the EpiPen is perceived as burdensome by most patients with venom allergy. For most patients, an EpiPen is an unsuitable definitive treatment. As VIT enables patients with venom allergy to get rid of the EpiPen, patients should be offered VIT

Today in Allergy/Anaphylaxis...keeping you current

Receive free subspecialty "5-minute updates" via email

Allergic rhinitis with negative skin tests: Does it exist
Allergy and Asthma Proceedings, 10/13/09

Objective assessments of allergic and nonallergic rhinitis in young children
Allergy, 09/21/09

Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09

See All of Allergy/Anaphylaxis

Today in Vaccine/Immunotherapy...keeping you current

Receive free subspecialty "5-minute updates" via email

Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09

Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies
International Journal of Epidemiology, 10/14/09

Will treatment of rheumatoid arthritis with an IL-6R inhibitor help facilitate the age of remission?
Expert Opinion on Investigational Drugs, 10/13/09

See All of Vaccine/Immunotherapy